SiBone (SIBN)
(Delayed Data from NSDQ)
$14.20 USD
-0.41 (-2.81%)
Updated May 3, 2024 04:00 PM ET
After-Market: $14.18 -0.02 (-0.14%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Price, Consensus and EPS Surprise
SIBN 14.20 -0.41(-2.81%)
Will SIBN be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for SIBN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SIBN
Organon (OGN) Gears Up to Report Q1 Earnings: What's in Store?
What's in Store for DENTSPLY SIRONA (XRAY) in Q1 Earnings?
SIBN: What are Zacks experts saying now?
Zacks Private Portfolio Services
What's in Store for Cardinal Health (CAH) in Q3 Earnings?
Si-Bone (SIBN) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Factors Setting the Tone For Lantheus' (LNTH) Q1 Earnings
Other News for SIBN
SI-BONE To Present at BofA Securities 2024 Healthcare Conference on May 14, 2024
Piper Sandler Keeps Their Buy Rating on SI-Bone (SIBN)
Analysts’ Opinions Are Mixed on These Healthcare Stocks: SI-Bone (SIBN), Conmed (CNMD) and Chemed (CHE)
Truist Financial Sticks to Their Buy Rating for SI-Bone (SIBN)
SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024